Clinical Trial Update: Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial update on nitazoxanide and escitalopram in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Escitalopram (escitalopram)
• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Tanta University | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED